Natera, Inc. operates as a diagnostics company. The Company provides preconception and prenatal genetic testing services. Natera also offers pre-implantation genetic diagnosis, aneuploidy screening, translocation, and single gene testing services.

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

S-3 | Registration statement for specified transactions by certain issuers

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Natera Inc (NTRA US)

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

S-3 | Registration statement for specified transactions by certain issuers

Current Report (Form 8-K | Period ending 2025-12-04)

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

Current Report (Form 8-K | Period ending 2025-11-06)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)